drugset / Trial / NCT00002876
Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with recurrent ependymomas following radiation therapy.
Timeline
- Start
- 1991-10
- Primary completion
- 1998-04
- Completion
- 2005-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Etoposide | Small molecule | — | — |